EXPANSIONSSTENT

Patent europeic · EP3861961 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3861961
Numer da la dumonda
EP21150336
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-05-2017
Publitgà
11-08-2021
Concedì
12-11-2025
La protecziun finescha il pli tard
14-05-2037
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
A61F 2/07 (2013.01)
A61F 2/89 (2013.01)
A61F 2/915 (2013.01)
A61F 2/24 (2006.01)
A61F 2/82 (2013.01)
Prioritad
US 201662337255 P 16.05.2016
US 201662374689 P 12.08.2016
US 201662414593 P 28.10.2016
US 201662424994 P 21.11.2016
US 201662430843 P 06.12.2016
US 201762480121 P 31.03.2017
Derivà da
EP17799967
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2026

    Midada

    Published in Swissreg on 23.09.2026

  2. 12-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 12.11.2025

Partidas

Possessur

Elixir Medical Corporation

920 N. McCarthy Boulevard, Milpitas, CA 95035, US

Inventur

SIRHAN, Motasim

Los Altos, CA 94022, US

YAN, John

Los Gatos, CA 95030, US

BHAT, Vinayak

Los Gatos, CA 95030, US

PARASCHAC, Joseph

Campbell, CA 95008, US

CRYER, Brett

Lafayette, CA 94549, US

SERNA, Benjamyn

Gilroy, CA 95020, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.